1-11 of 11
Andrew H. Lipsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Therapies Following Discontinuation of Non-Covalent Bruton's Tyrosine Kinase Inhibitors for Patients with Chronic Lymphocytic Leukemia and Richter Transformation: Results from an International, Multicenter Study

Meghan C. Thompson, Seema A. Bhat, Wojciech Jurczak, Krish Patel, Nirav N. Shah, Jennifer A. Woyach, Catherine C. Coombs, Toby A. Eyre, Michal Danecki, Monika Dlugosz-Danecka, Neil Bailey, Joanna M. Rhodes, Nicole Lamanna, Andrew H. Lipsky, Jeffrey Jensen, Adam Kidwell, Eytan M. Stein, Monica Shah, Jennifer R. Brown, Andriy Derkach, Anthony R. Mato, Lindsey Roeker
Journal: Blood
Blood (2024) 144 (Supplement 1): 1870.
https://doi.org/10.1182/blood-2024-194748
Published: 2024
Journal Articles

Diagnostic Utility of the 18 f-FDG PET/CT Scan in Solid Organ Transplant Patients with EBV Reactivation at Risk for Post-Transplant Lymphoproliferative Disorder

Hua-Jay J Cherng, Rebecca Scalabrino, Patrick Gould, Alexander Sanjurjo, Brian Cuzzo, Saagar Jain, Hong Y Ma, Maegan Ford, Evelyn H. Orlando, Dorine De Jong, Manuela A Orjuela, Andrew H. Lipsky, Seda S. Tolu, Barbara Pro, Jennifer E. Amengual, Kathleen M Capaccione
Journal: Blood
Blood (2024) 144 (Supplement 1): 3077.
https://doi.org/10.1182/blood-2024-194265
Published: 2024
Journal Articles

Topic Modeling of Genotyping of Transcriptomes Reveals Collaboration between BTK C481S -Mutant and Wild Type Cells in Btki-Resistant Chronic Lymphocytic Leukemia

Ramon Massoni-Badosa, Joshua S. Schiffman, Barun Pradhan, Rebecca M. Murray, Andrew H. Lipsky, Debra Van Egeren, Danny Luan, Shirley Chen, Ronan Chaligne, Kai Beattie, Alyssa Indart, Nada Chraiki, Neville Dusaj, Erica B. Bhavsar, Chelston Ang, Anna S. Nam, Federico Gaiti, Paulina Chamely, Nathaniel D. Omans, Preeti Trisal, Anita K. Gandhi, Kyu-Tae Kim, Rafael Schulman, Franco Izzo, Gavriel Mullokandov, Chingiz Underbayev, Jan A. Burger, Adrian Wiestner, Elisa Ten Hacken, John N. Allan, Jennifer A. Woyach, Richard R. Furman, Dan A. Landau
Journal: Blood
Blood (2024) 144 (Supplement 1): 4610.
https://doi.org/10.1182/blood-2024-205727
Published: 2024
Journal Articles

The Effect of Preemptive Rituximab Treatment in Patients with EBV Viremia after Solid Organ Transplantation on the Development of Post-Transplant Lymphoproliferative Disorder

Evelyn H. Orlando, Patrick Gould, Brian Cuzzo, Maegan Ford, Yuxuan Chen, Alexander Sanjurjo, Benjamin May, Demetra Tsapepas, Rebecca J. Leeman-Neill, Govind Bhagat, Geoffrey Dube, Heather Morris, Selim Arcasoy, Farhana Latif, Mercedes Martinez, Marcus Pereira, Andrew H. Lipsky, Ahmed Sawas, Ran Reshef, Barbara Pro, Hua-Jay J. Cherng, Jennifer E. Amengual
Journal: Blood
Blood (2023) 142 (Supplement 1): 990.
https://doi.org/10.1182/blood-2023-177823
Published: 2023
Journal Articles

Time-Limited Bendamustine, Rituximab, and Venetoclax (BR-VR) in Untreated Chronic Lymphocytic Leukemia (CLL): High Rates of Undetectable Minimal Residual Disease Remissions

Andrew H. Lipsky, Brian T. Hill, Allison Winter, Spencer Henick Bachow, Aaron D. Viny, Todd L. Rosenblat, Joseph Jurcic, Nicole Lamanna
Journal: Blood
Blood (2023) 142 (Supplement 1): 3274.
https://doi.org/10.1182/blood-2023-189718
Published: 2023
Journal Articles

The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation

Evelyn Orlando, Maegan Ford, Zhezhen Jin, Andrew H. Lipsky, Ahmed Sawas, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2022) 140 (Supplement 1): 12085–12086.
https://doi.org/10.1182/blood-2022-158050
Published: 2022
Journal Articles

Response to COVID-19 Infection and Vaccination in the CLL Population: A Large Single-Center Experience

Alexander Coltoff, Andrew H. Lipsky, Todd L. Rosenblat, Jennifer E. Amengual, Mark L Heaney, Joseph G. Jurcic, Nicole Lamanna
Journal: Blood
Blood (2022) 140 (Supplement 1): 9893–9895.
https://doi.org/10.1182/blood-2022-167191
Published: 2022
Journal Articles

First in Human (FIH) Study of GFH009, a Highly Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, in Patients with Relapsed/Refractory (r/r) Hematologic Malignancies

Junyuan Qi, Keshu Zhou, Wenbin Qian, Aimin Zang, Tapan M. Kadia, Andrew H. Lipsky, Yanli Yang, Yu Wang, Haige Shen, Bo Zheng, Chanli Zheng, Dragan Cicic, Jianxiang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9473–9474.
https://doi.org/10.1182/blood-2022-159844
Published: 2022
Journal Articles

Treatment Modalities Effect on Outcome in Post-Transplant Lymphoproliferative Disorder

Maegan Ford, Evelyn Orlando, Zhezhen Jin, Andrew H. Lipsky, Ahmed Sawas, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2022) 140 (Supplement 1): 3794–3795.
https://doi.org/10.1182/blood-2022-163813
Published: 2022
Journal Articles

Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder

Maegan Ford, Evelyn Orlando, Zhezhen Jin, Andrew H. Lipsky, Ahmed Sawas, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2022) 140 (Supplement 1): 3777–3778.
https://doi.org/10.1182/blood-2022-160147
Published: 2022
Journal Articles

High Rates of Undetectable Minimal Residual Disease Remissions with Time-Limited Bendamustine, Rituximab, and Venetoclax (BR-VR) in Untreated Chronic Lymphocytic Leukemia (CLL)

Andrew H. Lipsky, Brian T. Hill, Allison M. Winter, Joseph G. Jurcic, Mark L. Heaney, Todd L. Rosenblat, Matthew Chiaramonte, Hanna Weissbrot, Nicole Lamanna
Journal: Blood
Blood (2021) 138 (Supplement 1): 1555.
https://doi.org/10.1182/blood-2021-150914
Published: 2021